Independent fund research. Built on SEC filings.

How we research funds

ETF · Mid-Cap · Pacer

Pacer S&P MidCap 400 Quality FCF Aristocrats ETF (MCOW)

Ticker MCOW · Index fund · · Holdings as of Jul 31, 2026

Expense ratio
0.49%$49/yr per $10k
Net assets
$1.1Mall share classes
Holdings
78

Bottom line

Is MCOW a good fund? The bottom line

MCOW is an index mid-cap ETF from Pacer.

Annual fees run 0.49% — about $49 a year on every $10,000 invested, cheaper than 86% of mid-cap funds we track.

With $1.1 million in net assets and 78 holdings, its largest position is Everpure Inc (4.9%) and the top 10 make up 32.5% of the portfolio.

What stands out

  • Low cost: cheaper than 86% of mid-cap peers

What to watch

  • Small fund ($1.1 million) — small funds are likelier to close

Updated Nov 19, 2026

What MCOW invests in

The Pacer S&P MidCap 400 Quality FCF Aristocrats ETF (the Fund) is an exchange traded fund (ETF) that seeks to track the total return performance, before fees and expenses, of the S&P MidCap 400 Quality FCF Aristocrats Index (the Index).

The Fund employs a rules-based, passive management (or indexing) investment approach designed to track the total return performance, before fees and expenses, of the Index. The Index S&P Dow Jones Indices LLC (the Index Provider) compiles, maintains and calculates the Index, which measures the performance of companies within the S&P MidCap 400 Index (the S&P MidCap 400) that have had positive free cash flow (FCF) for at least seven consecutive years and simultaneously have high FCF margin and high FCF return on invested capital (ROIC) relative to the other companies in the S&P MidCap 400. The initial Index universe is derived from the component companies of the S&P MidCap 400 Index. The S&P MidCap 400 is comprised of common stocks of approximately 400 mid-capitalization companies that generally represent the mid-cap segment of the U.S. equity market. Free Cash Flow (FCF): net cash flow…

From the fund's prospectus (filed Feb 27, 2026).

What MCOW costs

On a $10,000 investment, MCOW's 0.49% expense ratio costs about $49 a year. The median mid-cap fund charges 0.88%.

See the full MCOW fee table →

MCOW top 10 holdings

#Holding% of fund
1Everpure Inc P4.91%
2Manhattan Associates Inc MANH3.65%
3Lattice Semiconductor Corp LSCC3.62%
4Docusign Inc DOCU3.60%
5Medpace Holdings Inc MEDP3.58%
6Sterling Infrastructure Inc STRL3.03%
7Exelixis Inc EXEL2.67%
8Neurocrine Biosciences Inc NBIX2.57%
9Jazz Pharmaceuticals PLC JAZZ2.52%
10Mueller Industries Inc MLI2.32%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 32.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to MCOW

More funds like MCOW →

MCOW FAQ

What is the expense ratio of MCOW?
MCOW's expense ratio is 0.49%, which works out to about $49 a year for every $10,000 invested.
Is MCOW a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 86% of mid-cap peers; small fund ($1.1 million) — small funds are likelier to close. This is general information, not personalized advice.
What does MCOW hold?
MCOW's largest holdings are Everpure Inc (4.9%), Manhattan Associates Inc (3.7%), Lattice Semiconductor Corp (3.6%), Docusign Inc (3.6%), Medpace Holdings Inc (3.6%). It holds 78 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages MCOW?
MCOW is offered by Pacer through Pacer Funds Trust.